Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

GCSF-R expression in myelodysplastic and myeloproliferative disorders and blast dysmaturation in CML.

Authors: Hanumanthu, VS  Pirruccello, SJ 
Citation: Hanumanthu VS and Pirruccello SJ, Am J Clin Pathol. 2013 Aug;140(2):155-64. doi: 10.1309/AJCPCLHZR5KUHUBM.
Pubmed: (View Article at PubMed) PMID:23897249
DOI: Full-text: DOI:10.1309/AJCPCLHZR5KUHUBM

OBJECTIVES: To characterize granulocyte colony-stimulating factor receptor (CD114) expression in normal (n = 20), myelodysplastic (n = 34), and chronic myelogenous leukemia (CML; n = 5) bone marrow by flow cytometry. METHODS: Clinical bone marrow samples were analyzed using CD33/CD114/CD34/CD117/CD45. CD114 density (mean fluorescence intensity) and cellular distribution were evaluated on early blasts (CD33-), late blasts (CD33+), promyelocytes, and granulocytes. RESULTS: Normal CD114 acquisition occurred on early blasts, peaked on promyelocytes, and decreased on granulocytes. Forty percent of CD34+ blasts expressed CD114 and one-third were early blasts. In myelodysplastic syndromes, altered CD114 distribution was more informative than density changes. In CML, CD114 density was significantly decreased on early blasts and expression was essentially limited to late blasts. We observed a specific blast dysmaturation pattern in CML involving CD33, CD34, and CD114 that was 83% sensitive and 100% specific in initial diagnosis. CONCLUSIONS: CD114 provides useful additional detail in phenotypic assessment of hematopoietic precursor maturation.

Annotation

Disease Annotations
Objects Annotated

Additional Information

 
CRRD Object Information
CRRD ID: 10450501
Created: 2016-01-14
Species: All species
Last Modified: 2016-01-14
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.